JNJ Related Press Releases

May 21, 2013 02:05 AM Cordis Showcases Cardiovascular Innovations at EuroPCR 2013

May 15, 2013 06:19 PM Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data

May 15, 2013 04:15 PM SIMPONI® (golimumab) Receives FDA Approval for Ulcerative Colitis

May 13, 2013 05:16 PM Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter

May 13, 2013 08:00 AM U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C

May 9, 2013 09:49 AM First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial Fibrillation

May 9, 2013 09:01 AM Human Performance Institute Division of Johnson & Johnson’s Wellness & Prevention, Inc. Announces New, Web-based Energy Management Program

May 8, 2013 08:50 AM Biosense Webster Showcases Cutting Edge Innovation and Leadership in AF Ablation at HRS Annual Scientific Sessions 2013

May 7, 2013 06:00 AM Davis Names Top 25 Brand Leaders for 2012

May 6, 2013 08:30 AM FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures

May 6, 2013 08:00 AM Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma

May 3, 2013 06:32 PM FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures

May 2, 2013 05:00 PM Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liv

May 1, 2013 03:05 PM First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting

May 1, 2013 12:07 PM Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration

May 1, 2013 08:34 AM First Manhattan Comments on Addition to Vivus’ Board of Directors

Apr 25, 2013 10:37 AM Johnson & Johnson Announces Dividend Increase of 8.2%

Apr 24, 2013 08:06 AM Janssen Therapeutics LINCC™ Program Continues its Commitment to Underserved Populations with Charitable Contributions to 16 HIV/AIDS Organizations Across the U.S.

Apr 23, 2013 10:04 AM Johnson & Johnson to Host Pharmaceuticals Business Review

Apr 22, 2013 06:46 AM Latest news in modern diabetes management now available online for Health Care professionals

Apr 18, 2013 09:50 AM Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan

Apr 18, 2013 09:25 AM BabyCenter® Reveals the Latest Profile of the 21st Century Social Mom: Her World Is Social

Apr 18, 2013 08:00 AM Richard Petty Teams Up With Janssen Biotech to Launch Show Your Stripes for Prostate Cancer Awareness

Apr 16, 2013 07:45 AM Johnson & Johnson Reports 2013 First-Quarter Results:

Apr 11, 2013 07:47 AM Johnson & Johnson to Webcast Annual Meeting of Shareholders

Apr 9, 2013 07:17 AM Look And Feel Great This Spring, Despite Allergy Symptoms

Apr 8, 2013 06:30 AM Ibrutinib Receives Third Oncology Breakthrough Therapy Designation from U.S. Food and Drug Administration

Apr 4, 2013 08:50 AM Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures

Apr 3, 2013 02:25 PM Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study

Mar 28, 2013 05:00 PM Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C